Glaxo scores with Olympic anti-doping ads

GSKSmallLogo

Throwing its weight--and $31 million--behind the London Olympics qualified GlaxoSmithKline ($GSK) as a good corporate citizen. But as it turns out, the company is getting its money's worth in publicity. Thanks to a savvy marketing move--setting up an anti-doping lab--Glaxo has made so many headlines and newscasts that it would be easier to count which major media haven't run a feature.

Now, Glaxo's Olympic advertising is turning heads. TV ads, posters and billboards have gone up all over the U.K., focusing, again, on the anti-doping lab. And these are no seen-it-all-before Olympic-ring celebrations. Glaxo's TV commercials do take the usual approach of featuring home-country athletes, but forego hackneyed crowd shots and swelling, sentimental music.

 

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

Take the commercial featuring British track star Marlon Devonish. It begins in a crowded, screaming stadium, but then swoops through Devonish's body with its swarming red blood cells, firing synapses, expanding lungs, and fast-beating heart--interspersed with rapid-fire images of fast-moving forces of nature. A tornado, for instance. When the visual stream shows hair standing on end, ours did, too.

It all ends with an anti-doping tagline: The Crowd Is My Only Drug. The implication: Devonish's body is gearing up for action quite well on its own adrenaline rush, thank you.



Related Articles:
As blockbuster drugs fade, so does TV advertising
Glaxo sales slump in Europe, U.S. on price cuts, generics
FDA cites promos from Astellas, Novartis and GSK